Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer

M El-Tanani, H Nsairat, AA Aljabali… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction The resistance to chemotherapy is a significant hurdle in breast cancer
treatment, prompting the exploration of innovative strategies. This review discusses the …

Potential of trehalose and sucrose-raffinose combination instead of sucrose applied to the cytarabine/daunorubicin co-loaded lyophilized liposome: Investigation on …

B Liu, Z Liu, P Wang, Z Huang, Q Wang… - Journal of Drug Delivery …, 2024 - Elsevier
Sucrose (300 mM) is a lyoprotectant for CPX-351 (cytarabine/daunorubicin co-loaded
liposome). However, its high hygroscopicity leads to crystallization, limiting long-term …

Meta-analysis of nano-phytosomes: unleashing the potential of plant-derived compounds for advancing cancer therapy

A Al-Samydai, H Nsairat, MN Abu Hajleh… - Natural Product …, 2024 - Taylor & Francis
Nano-phytosomes are considered as an efficient drug delivery system for phytochemicals.
Phytosomes enhance stability and significantly improves phytochemicals bioavailability and …

Use of antioxidant nanoliposomes for co-delivery of PTEN plasmids and plumbagin to induce apoptosis in hepatic cancer cells

S Bhagat, S Singh - Biomedical Materials, 2024 - iopscience.iop.org
Hepatocellular carcinoma remains a challenging contributor to the global cancer and related
mortality, and claims approximately 800,000 deaths each year. Dysregulation or loss of …

Applications of liposomes for overcoming cancer drug resistance

R Hosseinpour-Moghadam, F Taghizadeh… - … for Cancer Research, 2024 - Elsevier
Drug resistance is one of the significant obstacles to achieve desired therapeutic results in
patients with various types of cancers, which, through a broad spectrum of mechanisms …